The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay
Yoshihiko Sakurai
Journal of Thrombosis and Haemostasis, 2006
View PDFchevron_right
The value of the chromogenic activity assay in diagnosis and therapeutic monitoring of hemophilia of those with hemophilia
Stefan Tiefenbacher
View PDFchevron_right
Applicability of the Thrombin Generation Test to Evaluate the Hemostatic Status of Hemophilia A Patients in Daily Clinical Practice
Carmen Palomo Antequera
Journal of Clinical Medicine
View PDFchevron_right
Prediction of individual factor VIII or IX level for the correction of thrombin generation in haemophilic patients
Michel COURNIL
Haemophilia, 2018
View PDFchevron_right
Blood Coagulation in Hemophilia A and Hemophilia C
Kevin Cawthern
Blood
View PDFchevron_right
An Evaluation of the Activated Partial Thromboplastin Time Waveform
Kaname Nakatani
Clinical and Applied Thrombosis/Hemostasis
View PDFchevron_right
A modified chromogenic assay for the measurement of very low levels of factor VIII activity (FVIII:C
Rivki Yatuv
Haemophilia, 2006
View PDFchevron_right
Diagnosis of factor VIII deficiency
Waander Van Heerde
Haemophilia, 2008
View PDFchevron_right
Optical and Mechanical Clot Detection Methodologies: A Comparison Study for Routine Coagulation Testing
nilgun tekkesin
Journal of Clinical Laboratory Analysis, 2012
View PDFchevron_right
Correlation to FVIII:C in Two Thrombin Generation Tests: TGA-CAT and INNOVANCE ETP
Ivo V Elezovic
Mediterranean journal of hematology and infectious diseases, 2017
View PDFchevron_right
Comparison of thrombin generation for paired-platelet-rich plasma collected with and without corn trypsin inhibitor from hemophiliacs treated with factor-VIII inhibitor bypassing agents
Maria Mancuso
Journal of Thrombosis and Haemostasis, 2012
View PDFchevron_right
Use of high-resolution techniques for the characterization of clotting factor VIII
Andreas Rizzi
Journal of Chromatography A, 1999
View PDFchevron_right
Sensitive measurement of clinically relevant factor VIII levels in thrombin generation assays requires presence of factor XIa
William Derberg
Thrombosis and Haemostasis
View PDFchevron_right
Detection of factor VIII inhibitors with the partial thromboplastin time
Carol Kasper
Blood, 1977
View PDFchevron_right
Mechanism of factor VIIa-dependent coagulation in hemophilia blood
Saulius Butenas
Blood, 2002
View PDFchevron_right
Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time
Tomas Lindahl
Analytical Chemistry, 2011
View PDFchevron_right
Effect of factor VIII on tissue factor-initiated spatial clot growth
Fazly Ataullakhanov
Thrombosis and haemostasis, 2003
View PDFchevron_right
One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype
N. Cabrera
Haemophilia, 2008
View PDFchevron_right
Multicenter Study of Diagnostic Tool for Patients with Hemophilia: From Bedside to Comprehensive Investigations
noppawan tangbubpha
The application of clinical genetics, 2023
View PDFchevron_right
Clinicohematological Study of Hemophilia Patients in Bhopal
Neha Banseria
Journal of Evolution of medical and Dental Sciences, 2014
View PDFchevron_right
Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation
Rashid Kazmi
British Journal of Haematology, 1997
View PDFchevron_right
Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B
Jean-Claude BORDET
Thrombosis and Haemostasis, 2005
View PDFchevron_right
Journal of Molecular and Genetic Medicine Mutation Screening of the Factor VIII Gene in Hemophilia A in Saudi Arabia: Two Novel Mutations and Genotype-Phenotype Correlation
Taher Mohiuddin, Tarek Owaidah
View PDFchevron_right
A specific and sensitive activated partial thromboplastin time (APTT)-based factor VIII inhibitor screening assay
Kanjaksha Ghosh
Clinical Chemistry and Laboratory Medicine (CCLM), 2014
View PDFchevron_right
Comparison of the behavior of normal factor IX and the factor IX BM variant hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sources
Carol Kasper
American Journal of Hematology, 1993
View PDFchevron_right
Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A
Benny Benny
British Journal of Haematology, 2007
View PDFchevron_right
Methodology of the one-stage assay of Factor VIII (VIII:C)
J. Over
Scandinavian journal of haematology. Supplementum, 1984
View PDFchevron_right
Mutation Screening of the Factor VIII Gene in Hemophilia A in Saudi Arabia: Two Novel Mutations and Genotype-Phenotype Correlation
Mohammad Athar
J Mol Genet Med , 2016
View PDFchevron_right
Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa
Daniel Bolliger
Haemophilia, 2009
View PDFchevron_right
Discordant fibrin formation in hemophilia
Saulius Butenas
Journal of Thrombosis and Haemostasis, 2009
View PDFchevron_right
Thrombin generation and phenotypic correlation in haemophilia A
Ana-Rebeca Jaloma
Haemophilia, 2005
View PDFchevron_right
Hemophilia A and B are associated with abnormal spatial dynamics of clot growth
Fazly Ataullakhanov
Biochimica et Biophysica Acta (BBA) - General Subjects, 2002
View PDFchevron_right
The effects of hemolysis on plasma prothrombin time and activated partial thromboplastin time tests using photo-optical method
yetti hernaningsih
Medicine
View PDFchevron_right
Calibrated automated thrombin generation and modified thromboelastometry in haemophilia A
Alex Gatt
Thrombosis Research, 2009
View PDFchevron_right
Discrepancies between APTT results determined with different evaluation modes on automated coagulation analyzers
Marija Milos, Desiree Coen Herak
International Journal of Laboratory Hematology, 2010
View PDFchevron_right